Sexpert : Seksuele gezondheid in Vlaanderen

Buysse, Ann; Caen, Maya; Dewaele, Alexis; Enzlin, Paul; Lievens, John; T’Sjoen, Guy; Houtte, Mieke Van; Vermeersch, Hans

doi:10.26530/oapen_472415

Cited by 52 publications

(59 citation statements)

References 68 publications

(100 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mean duration of an interview was 84 minutes and no token was provided. The details of the study design have been described elsewhere (Buysse et al, 2013).…”

Section: Methods Participantsmentioning

confidence: 99%

“…In order to comply with its first aim, this study used data from the survey "Sexual Health in Flanders" (Buysse et al, 2013), a large-scale representative survey on sexuality, sexual health, and relationships in Flanders (the northern, Flemish-speaking part of Belgium with about 6 million inhabitants). The survey contained extensive information on sexual health characteristics and demographic, biomedical, psychological, and sociocultural correlates.…”

Section: Methods Participantsmentioning

confidence: 99%

“…The items on sociodemographic variables are described elsewhere (Buysse et al, 2013;Dewaele, Caen, & Buysse, 2014).…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Prevalence of Gender Nonconformity in Flanders, Belgium

et al. 2015

Self Cite

View full text Add to dashboard Cite

Gender nonconformity refers to the extent to which a person's gender identity, gender role and/or gender expression differs from the cultural norms prescribed for people of a particular sex, within a certain society and era. Most data on gender nonconformity focus on the prevalence of gender dysphoria (which also includes a distress factor) or on the number of legal sex changes. However, not every gender nonconforming individual experiences distress or applies for treatment. Population-based research on the broad spectrum of gender nonconformity is scarce and more information on the variance outside the gender binary is needed. This study aimed to examine the prevalence of gender incongruence (identifying stronger with the other sex than with the sex assigned at birth) and gender ambivalence (identifying equally with the other sex as with the sex assigned at birth) based on two population-based surveys, one of 1,832 Flemish persons and one of 2,472 sexual minority individuals in Flanders. In the general population, gender ambivalence was present in 2.2% of male and 1.9% of female participants, whereas gender incongruence was found in 0.7% of men and 0.6% of women. In sexual minority individuals, the prevalence of gender ambivalence and gender incongruence was 1.8% and 0.9% in men and 4.1% and 2.1% in women, respectively. With a current Flemish population of about 6 million, our results indicate a total of between 17,150 and 17,665 gender incongruent men and between 14,473 and 15,221 gender incongruent women in Flanders.

show abstract

“…The mean duration of an interview was 84 minutes and no token was provided. The details of the study design have been described elsewhere (Buysse et al, 2013).…”

Section: Methods Participantsmentioning

confidence: 99%

Section: Methods Participantsmentioning

confidence: 99%

See 1 more Smart Citation

Prevalence of Gender Nonconformity in Flanders, Belgium

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

“…This control group was randomly selected (three control men and three control women for each subject) and was recruited from a population-based study in Flanders. The methods used for this study have been described elsewhere (16). Briefly, the control population was recruited from a survey of sexual health characteristics and biomedical, psychological, demographic, and sociocultural correlates in persons aged between 14 and 80 years.…”

Section: Study Population and Study Proceduresmentioning

confidence: 99%

Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study

Wierckx¹,

Elaut

Declercq

et al. 2013

European Journal of Endocrinology

278

216

View full text Add to dashboard Cite

Objective: This study evaluated the short-and long-term cardiovascular-and cancer-related morbidities during cross-sex hormone therapy in a large sample of trans persons. Subjects and methods: A specialist center cross-sectional study compared 214 trans women (male-to-female transsexual persons) and 138 trans men (female-to-male trans persons) with an age-and gender-matched control population (1-3 matching). The participants were on cross-sex hormone therapy for an average of 7.4 years. We assessed physical health and possible treatmentrelated adverse events using questionnaires. Results: Five percent of trans women experienced venous thrombosis and/or pulmonary embolism during hormone therapy. Five of these adverse events occurred during the first year of treatment, while another three occurred during sex reassignment surgery. Trans women experienced more myocardial infarctions than the control women (PZ0.001), but a similar proportion compared with control men. The prevalence of cerebrovascular disease (CVD) was higher in trans women than in the control men (PZ0.03). The rates of myocardial infarction and CVD in trans men were similar to the control male and female subjects. The prevalence of type 2 diabetes was higher in both trans men and women than in their respective controls, whereas the rates of cancer were similar compared with the control men and women. Conclusion: Morbidity rate during cross-sex hormone therapy was relatively low, especially in trans men. We observed a higher prevalence of venous thrombosis, myocardial infarction, CVD, and type 2 diabetes in trans women than in the control population. Morbidity rates in trans men and controls were similar, with the exception of the increased prevalence of type 2 diabetes.

show abstract

“…The first study draws on data from the survey 'Sexual Health in Flanders' (Buysse et al 2013). Respondents (between 14 and 80 years of age) were randomly drawn from the Belgian National Register.…”

Section: Research Proceduresmentioning

confidence: 99%

Comparing Survey and Sampling Methods for Reaching Sexual Minority Individuals in Flanders

Dewaele

Caen

Buysse

2014

Journal of Official Statistics

Self Cite

View full text Add to dashboard Cite

As part of a large sexual health study, we used two different approaches to target Sexual Minority Individuals (SMIs). Firstly, we drew on a probability sample (1,832 respondents aged 14-80) of the Flemish population in Belgium. Secondly, we set up a targeted sampling design followed by an Internet survey. Our focus was to explore how two different sampling procedures and survey designs could lead to differences in sample characteristics. Results showed that for female SMIs (we excluded male SMIs from the analyses due to their low numbers) the population sample differed from the Internet sample in terms of sociodemographic characteristics (the latter included younger and more highly educated respondents) and scores on sexual orientation dimensions (the population sample included more respondents who didn’t identify as lesbian or bisexual but reported same-sex sexual experiences and desire). Respondents’ scores on sexual health indicators differed between the samples for two of the seven variables. We discuss implications for improving the quality and validity of nonrandom samples.

show abstract

Sexpert : Seksuele gezondheid in Vlaanderen

Cited by 52 publications

References 68 publications

Prevalence of Gender Nonconformity in Flanders, Belgium

Prevalence of Gender Nonconformity in Flanders, Belgium

Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study

Comparing Survey and Sampling Methods for Reaching Sexual Minority Individuals in Flanders

Contact Info

Product

Resources

About